| Primary |
| Chronic Obstructive Pulmonary Disease |
50.4% |
| Asthma |
20.5% |
| Hypertension |
15.4% |
| Drug Use For Unknown Indication |
3.4% |
| Maternal Condition Affecting Foetus |
3.4% |
| Insomnia |
1.7% |
| Osteoarthritis |
1.7% |
| Hiv Infection |
0.9% |
| Lower Respiratory Tract Infection |
0.9% |
| Sacroiliitis |
0.9% |
| Seasonal Allergy |
0.9% |
|
| Chronic Obstructive Pulmonary Disease |
22.2% |
| Infection |
16.7% |
| Ventricular Extrasystoles |
8.3% |
| Asthma |
5.6% |
| Osteoporosis |
5.6% |
| Acute Respiratory Failure |
2.8% |
| Amenorrhoea |
2.8% |
| Angioedema |
2.8% |
| Cerebrovascular Accident |
2.8% |
| Condition Aggravated |
2.8% |
| Cushing's Syndrome |
2.8% |
| Drug Exposure During Pregnancy |
2.8% |
| Kidney Malformation |
2.8% |
| Limb Reduction Defect |
2.8% |
| Myalgia |
2.8% |
| Nasopharyngeal Disorder |
2.8% |
| Oedema Peripheral |
2.8% |
| Oral Discomfort |
2.8% |
| Osteonecrosis |
2.8% |
| Pharyngeal Leukoplakia |
2.8% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
31.7% |
| Asthma |
22.4% |
| Product Used For Unknown Indication |
10.8% |
| Diabetes Mellitus |
5.0% |
| Hypertension |
3.4% |
| Atrial Flutter |
2.6% |
| Cough |
2.6% |
| Hiv Infection |
2.4% |
| Coronary Artery Disease |
2.2% |
| Allergic Sinusitis |
1.9% |
| Bronchopulmonary Aspergillosis Allergic |
1.9% |
| Sinusitis Fungal |
1.9% |
| Cor Pulmonale |
1.7% |
| Pneumonia |
1.7% |
| Cardiac Failure |
1.5% |
| Gastritis |
1.5% |
| Temporal Arteritis |
1.5% |
| Analgesic Asthma Syndrome |
1.1% |
| Erectile Dysfunction |
1.1% |
| Pain |
1.1% |
|
| Cystitis Haemorrhagic |
12.1% |
| Drug Ineffective |
10.3% |
| Drug Exposure During Pregnancy |
6.9% |
| Angina Unstable |
5.2% |
| Chronic Obstructive Pulmonary Disease |
5.2% |
| Drug Interaction |
5.2% |
| Dyspnoea |
5.2% |
| Laceration |
5.2% |
| Pneumonia |
5.2% |
| Weight Increased |
5.2% |
| Asthenia |
3.4% |
| Asthma |
3.4% |
| Condition Aggravated |
3.4% |
| Gastric Ulcer |
3.4% |
| Lactic Acidosis |
3.4% |
| Renal Failure Acute |
3.4% |
| Speech Disorder |
3.4% |
| Sudden Death |
3.4% |
| Thrombosis In Device |
3.4% |
| Urinary Retention |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.7% |
| Asthma |
18.3% |
| Drug Use For Unknown Indication |
16.8% |
| Chronic Obstructive Pulmonary Disease |
7.5% |
| Hypertension |
4.7% |
| Rheumatoid Arthritis |
3.8% |
| Atrial Fibrillation |
2.4% |
| Hiv Infection |
2.4% |
| Crohn's Disease |
1.6% |
| Non-small Cell Lung Cancer |
1.6% |
| Pain |
1.6% |
| Depression |
1.2% |
| Rectal Cancer |
1.2% |
| Osteoporosis |
1.1% |
| Diabetes Mellitus |
1.1% |
| Prophylaxis |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Cardiac Failure |
1.0% |
| Back Pain |
0.9% |
| Smoking Cessation Therapy |
0.9% |
|
| Vomiting |
14.6% |
| Pneumonia |
11.4% |
| Pyrexia |
6.4% |
| Myositis |
5.7% |
| Dyspnoea |
5.0% |
| Vision Blurred |
5.0% |
| Rash |
4.6% |
| Wheezing |
4.6% |
| Osteonecrosis |
4.3% |
| Asthma |
3.9% |
| Tremor |
3.9% |
| Death |
3.6% |
| Liver Function Test Abnormal |
3.6% |
| Sepsis |
3.6% |
| Syncope |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| International Normalised Ratio Increased |
3.2% |
| Respiratory Failure |
3.2% |
| Suicidal Ideation |
3.2% |
| Tachycardia |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Sinusitis |
50.0% |
|
|
